azacitidine has been researched along with Cirrhosis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 6 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| An, XF; Chen, C; Chen, MM; Jiang, H; Liu, HL; Si, ZL; Su, K; Tan, NH; Vaziri, ND; Wang, LX; Wu, WH; Zhang, ZH; Zhou, W | 1 |
| Gardner, J; Heenan, J; Hitchins, S; Mohamed, M; Shahidi, R; Sharma, A | 1 |
| Fan, X; Huang, T; Lang, Y; Li, X; Lv, Z; Sheng, Q; Wang, Q; Wang, R; Zhang, T; Zhao, Y; Zhen, J; Zhou, P | 1 |
| Du, Y; Lan, B; Wang, B; Wang, H; Xie, H; Zhang, S | 1 |
| Fujimoto, T; Futakuchi, A; Inoue, T; Inoue-Mochita, M; Takahashi, E; Tanihara, H; Yonemura, H | 1 |
| Bouvet, M; Hamada, K; Han, Q; Hoffman, RM; Inubushi, S; Kawaguchi, K; Nishino, H; Sugisawa, N; Tan, Y; Tashiro, Y; Unno, M; Yamamoto, J | 1 |
| Cao, W; Chen, F; Chen, X; Dai, J; Gao, Q; Shi, Y; Su, X; Wei, A; Zhang, L; Zhu, X | 1 |
| D'Haese, PC; Godderis, L; Moonen, L; Poels, K; Vervaet, BA | 1 |
| Fu, S; Shi, H; Sun, L; Xiao, Y; Xu, K; Ye, W; Zhang, X | 1 |
| Ahn, Y; Hong, MH; Jeong, HC; Jeong, HY; Jeong, MH; Kang, WS; Kim, YS; Kwon, JS | 1 |
| Chen, ZW; Shi, KH; Tao, H; Xu, SS; Yang, JJ; Zhan, HY; Zhou, X | 1 |
| Lu, Q; Luo, Y; Shu, Y; Wang, Y; Xiao, R | 1 |
| Baugh, J; Corrigan, N; Glezeva, N; Horgan, S; Ledwidge, M; McDonald, K; Neary, R; Tea, I; Watson, CJ | 1 |
| Chang, FC; Chang, YT; Chen, YM; Chiang, WC; Chou, YH; Chu, TS; Hsu, HL; Lai, CF; Lin, CH; Lin, SL; Pan, SY; Tsai, MH; Wu, MS; Yang, CC | 1 |
| Broquist, AH; Gayden, AE; Nanney, LB; Opalenik, SR; Raju, L; Russell, JD; Russell, SB; Trupin, KM; Williams, SM | 1 |
| Jin, L; Piao, J; Yang, S; Zhou, Y | 1 |
1 review(s) available for azacitidine and Cirrhosis
| Article | Year |
|---|---|
Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Biomarkers; CD27 Ligand; CD40 Antigens; Decitabine; DNA Methylation; Epigenesis, Genetic; Extracellular Matrix; Fibrosis; Histone Deacetylase Inhibitors; Histones; Humans; MicroRNAs; Protein Processing, Post-Translational; Proto-Oncogene Protein c-fli-1; Scleroderma, Systemic; Signal Transduction | 2015 |
15 other study(ies) available for azacitidine and Cirrhosis
| Article | Year |
|---|---|
Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho.
Topics: Adenine; Animals; Artemisinins; Azacitidine; beta Catenin; Biotin; DNA; DNA Modification Methylases; Fibrosis; Glucuronidase; HEK293 Cells; Humans; Kidney; Klotho Proteins; Mice; Proteasome Endopeptidase Complex; Renal Insufficiency, Chronic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ubiquitins; Ureteral Obstruction | 2022 |
Bone marrow fibrosis impact on response to azacitidine in myelodysplastic syndromes.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Fibrosis; Humans; Myelodysplastic Syndromes; Primary Myelofibrosis; Prospective Studies; Retrospective Studies; Treatment Outcome | 2022 |
ROS promote hyper-methylation of NDRG2 promoters in a DNMTS-dependent manner: Contributes to the progression of renal fibrosis.
Topics: Animals; Azacitidine; DNA Methylation; DNA, A-Form; Epigenesis, Genetic; Fibrosis; Methyltransferases; Mice; Reactive Oxygen Species; Renal Insufficiency, Chronic | 2023 |
DNMT1-induced miR-133b suppression via methylation promotes myocardial fibrosis after myocardial infarction.
Topics: Animals; Azacitidine; DNA Methylation; Fibrosis; Heart; MicroRNAs; Myocardial Infarction; Rats | 2023 |
DNA methyltransferase inhibitor suppresses fibrogenetic changes in human conjunctival fibroblasts.
Topics: Actins; Azacitidine; Cell Death; Cell Proliferation; Collagen Type I; Conjunctiva; DNA (Cytosine-5-)-Methyltransferases; Enzyme Inhibitors; Extracellular Matrix; Fibroblasts; Fibrosis; Humans; Promoter Regions, Genetic; Signal Transduction; Smad Proteins | 2019 |
Triple-Methyl Blockade With Recombinant Methioninase, Cycloleucine, and Azacitidine Arrests a Pancreatic Cancer Patient-Derived Orthotopic Xenograft Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carbon-Sulfur Lyases; Cell Proliferation; Cycloleucine; DNA Methylation; Fibrosis; Humans; Methionine; Mice, Nude; Necrosis; Pancreatic Neoplasms; Proof of Concept Study; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
Inhibition of DNA methylation de-represses peroxisome proliferator-activated receptor-γ and attenuates pulmonary fibrosis.
Topics: Animals; Azacitidine; Bleomycin; DNA Methylation; Fibroblasts; Fibrosis; Humans; Idiopathic Pulmonary Fibrosis; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR gamma; Promoter Regions, Genetic | 2022 |
Untargeted DNA-Demethylation Therapy Neither Prevents Nor Attenuates Ischemia-Reperfusion-Induced Renal Fibrosis.
Topics: Animals; Azacitidine; Collagen Type I; Cytokines; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Enzyme Inhibitors; Fibrosis; Kidney; Kidney Diseases; Kidney Tubules; Male; Mice; Mice, Inbred C57BL; Reperfusion Injury; Transforming Growth Factor beta | 2017 |
5-Aza-2'-deoxycytidine induces human Tenon's capsule fibroblasts differentiation and fibrosis by up-regulating TGF-β type I receptor.
Topics: Adult; Azacitidine; Cell Count; Cell Differentiation; Cells, Cultured; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; Enzyme Inhibitors; Female; Fibroblasts; Fibrosis; Humans; Male; Middle Aged; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Repressor Proteins; Tenon Capsule; Transforming Growth Factor beta; Up-Regulation | 2017 |
Protective role of 5-azacytidine on myocardial infarction is associated with modulation of macrophage phenotype and inhibition of fibrosis.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cells, Cultured; Fibroblasts; Fibrosis; Immunoenzyme Techniques; Macrophages; Male; Mice; Mice, Inbred BALB C; Myocardial Infarction; Nitric Oxide; Nitric Oxide Synthase; Peptidoglycan; Phenotype; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Ventricular Dysfunction, Left; Ventricular Remodeling | 2014 |
DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2.
Topics: Actins; Animals; Animals, Newborn; Azacitidine; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Fibroblasts; Fibrosis; Gene Silencing; Isoproterenol; Male; MAP Kinase Signaling System; Myocardium; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tumor Suppressor Proteins | 2014 |
Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
Topics: Actins; Animals; Azacitidine; Cardiomegaly; Carrier Proteins; Cells, Cultured; Collagen Type I; Collagen Type III; Disease Models, Animal; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Fibroblasts; Fibrosis; Gene Expression Regulation; Humans; Hypertension; Male; Myocytes, Cardiac; Rats, Inbred SHR; Rats, Inbred WKY; Transforming Growth Factor beta1; Ventricular Remodeling | 2016 |
DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.
Topics: Animals; Azacitidine; Basic Helix-Loop-Helix Transcription Factors; Collagen Type I; Collagen Type I, alpha 1 Chain; DNA Modification Methylases; Erythropoietin; Fibrosis; Mice; Mice, Transgenic; Myofibroblasts; Pericytes; Receptor, Platelet-Derived Growth Factor beta; Renal Insufficiency, Chronic | 2016 |
Epigenetically altered wound healing in keloid fibroblasts.
Topics: Acetylation; Azacitidine; Black or African American; Cell Division; Cells, Cultured; Culture Media; Decitabine; Dermis; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Fibroblasts; Fibrosis; Gene Expression Profiling; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Insulin-Like Growth Factor Binding Protein 5; Intercellular Signaling Peptides and Proteins; Keloid; Membrane Proteins; Oligonucleotide Array Sequence Analysis; Wound Healing | 2010 |
Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
Topics: Animals; Azacitidine; Body Weight; Bone Marrow Cells; Bromodeoxyuridine; Cardiomyopathy, Dilated; Cell Transdifferentiation; Collagen; Female; Fibrosis; Gene Expression Regulation; Heart Function Tests; Infusions, Intravenous; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Wistar; RNA, Messenger; Survival Analysis; Troponin T; Vascular Endothelial Growth Factor A | 2013 |